A CLINICAL EVALUATION OF HYPERKALAEMIA IN PATIENTS WITH RENAL IMPAIRMENT ON COMBINATION THERAPY OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN-RECEPTOR BLOCKER

被引：0
|
作者：
Goh, T. H. [1 ]
Tan, S. C. [1 ]
Fook-Chong, S. M. C. [1 ]
Wong, K. S. [1 ]
Chan, C. M. [1 ]
机构：
[1] Singapore Gen Hosp, Singapore, Singapore
来源：
NEPHROLOGY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A139 / A139
页数：1
相关论文
共 50 条
  • [41] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure
    McClellan, MB
    Loeb, JM
    Clancy, CM
    Francis, GS
    Jacobs, AK
    Kizer, KW
    O'Kane, ME
    Wolk, MJ
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) : 386 - 387
  • [42] Response to Uncritical Acceptance of Combination Treatment of Angiotensin II Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor in Nondiabetic Renal Disease Trial Results
    Kaplan, Norman M.
    HYPERTENSION, 2009, 53 (01) : E4 - E4
  • [43] Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: A systematic review and meta-analysis of Randomized controlled trials
    Lakhdar, Rachid
    Al-Mallah, Mouaz H.
    Lanfear, David E.
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (03) : 181 - 188
  • [44] Efficacy of Aliskiren for Patients with Hypertension Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin-Receptor Blockers
    Fujino, Noboru
    Araki, Tsutomu
    Yasuda, Toshihiko
    Terai, Hidenobu
    Konno, Tetsuo
    Sakata, Kenji
    Hayashi, Kenshi
    Kawashiri, Masaaki
    Ino, Hidekazu
    Yamagishi, Masakazu
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S157 - S157
  • [45] The Impact of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in patients with Clostridium difficile infection
    Patel, Shilpa M.
    Stashefsky, Evan
    Maroun, Marie-Claire
    Johnson, Leonard B.
    MEDICAL HYPOTHESES, 2011, 76 (06) : 813 - 815
  • [46] Intervention in the prescribing of the combination of an angiotensin converting enzyme inhibitor and an angiotensin-II receptor blocker
    Portilla, Alfredo
    Torres, Daniel
    Enrique Machado-Duque, Manuel
    Enrique Machado-Alba, Jorge
    ATENCION PRIMARIA, 2016, 48 (04): : 272 - 274
  • [47] Vascular protective effects of combined therapy of angiotensin receptor blocker and angiotensin-converting enzyme inhibitor in essential hypertension.
    Morimoto, Satoshi
    Tokoro, Toshiko
    Kikuchi, Sanae
    Yamahara, Hideki
    Imada, Takanobu
    Kohno, Keiko
    Masaki, Hiroya
    Takahashi, Nobuyuki
    Nishikawa, Mitsushige
    Iwasaka, Toshiji
    JOURNAL OF HYPERTENSION, 2006, 24 : 190 - 190
  • [48] Renoprotective effect of combination with angiotensin converting enzyme inhibitor and angiotensin receptor blocker in diabetic nephropathy with renal failure.
    Okada, T
    Nakao, T
    Matsumoto, H
    Hidaka, H
    Yoshino, M
    Nagaoka, Y
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 687A - 687A
  • [49] Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
    Lee, Hyun Woo
    Suh, Jae Kyung
    Jang, Eunjin
    Lee, Sang-Min
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (02): : 371 - 381
  • [50] Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy
    Rabi, D. M.
    Khan, N.
    Vallee, M.
    Hladunewich, M. A.
    Tobe, S. W.
    Pilote, L.
    CANADIAN JOURNAL OF CARDIOLOGY, 2008, 24 (06) : 491 - 496
12345